TY - JOUR T1 - Rheumatologists and Pulmonologists at Temple University Weather the COVID-19 Storm Together JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.200740 SP - jrheum.200740 AU - Roberto Caricchio AU - Gerard J. Criner Y1 - 2020/06/08 UR - http://www.jrheum.org/content/early/2020/06/25/jrheum.200740.abstract N2 - In recent commentaries from Lancet Rheumatology and The Journal of Rheumatology1,2, the authors eloquently illustrated the connection between the coronavirus disease 2019 (COVID-19) infection, the subsequent cytokine storm (CS) that ensues in a number of patients, and the potential efficacy of biologics that rheumatologists routinely use in their practices. Moreover, those biologics were originally investigated by rheumatologists for the treatment of numerous rheumatic conditions, including macrophage activating syndrome (MAS), a similar form of storm that resembles the one occurring in patients with COVID-193. ER -